NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

CVRX

CVRx Inc

Jun 30 • 04:00PM ET

5.88

Dollar change +0.06
Percentage change 1.03	%

Healthcare • Medical Devices • USA • NASD

Peers: MDT BSX ABT EW SYK ISRG ZBH TFX HOLX ALGN

| Held by: VTI IWM VXF IWO VTWO IWC VTWG RSSL DFAS DFAC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.19	Insider Own	40.53%	Shs Outstand	26.05M	Perf Week	2.80%
Market Cap	153.31M	Forward P/E	-	EPS next Y	-1.71	Insider Trans	1.98%	Shs Float	15.50M	Perf Month	-13.53%
Enterprise Value	101.06M	PEG	-	EPS next Q	-0.52	Inst Own	38.66%	Short Float	10.62%	Perf Quarter	-52.92%
Income	-51.55M	P/S	2.90	EPS this Y	24.25%	Inst Trans	3.54%	Short Ratio	3.87	Perf Half Y	-54.42%
Sales	52.87M	P/B	2.21	EPS next Y	14.98%	ROA	-43.73%	Short Interest	1.65M	Perf YTD	-53.59%
Book/sh	2.66	P/C	1.49	EPS next 5Y	14.95%	ROE	-76.01%	52W High	18.55 -68.30%	Perf Year	-47.36%
Cash/sh	3.94	P/FCF	-	EPS past 3/5Y	-7.91% -28.44%	ROIC	-43.14%	52W Low	4.30 36.77%	Perf 3Y	-11.58%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	57.87% 52.31%	Gross Margin	82.17%	Volatility	4.90% 6.16%	Perf 5Y	-
Dividend TTM	-	EV/Sales	1.91	EPS Y/Y TTM	11.86%	Oper. Margin	-95.89%	ATR (14)	0.41	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	13.45	Sales Y/Y TTM	25.62%	Profit Margin	-97.49%	RSI (14)	43.60	Recom	1.57
Dividend Gr. 3/5Y	- -	Current Ratio	14.83	EPS Q/Q	49.09%	SMA20	-4.02%	Beta	1.20	Target Price	11.00
Payout	-	Debt/Eq	0.73	Sales Q/Q	14.65%	SMA50	-8.55%	Rel Volume	0.28	Prev Close	5.82
Employees	206	LT Debt/Eq	0.72	Earnings	May 08 AMC	SMA200	-46.16%	Avg Volume	425.07K	Price	5.88
IPO	Jun 30, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	7.02% -7.69%	Trades		Volume	117,316	Change	1.03%

Date	Action	Analyst	Rating Change	Price Target Change
May-09-25	Downgrade	JP Morgan	Neutral → Underweight	$7
Jan-14-25	Upgrade	William Blair	Mkt Perform → Outperform
Sep-10-24	Initiated	Cantor Fitzgerald	Overweight	$14
Jul-11-24	Reiterated	Lake Street	Buy	$18 → $12
May-01-24	Resumed	Craig Hallum	Buy	$30 → $23
May-01-24	Downgrade	William Blair	Outperform → Mkt Perform
May-01-24	Downgrade	JP Morgan	Overweight → Neutral	$36 → $13
Jan-31-23	Initiated	Lake Street	Buy	$20
Jul-18-22	Initiated	Craig Hallum	Buy	$15
Jul-26-21	Initiated	William Blair	Outperform
Jul-26-21	Initiated	Piper Sandler	Overweight	$26
Jul-26-21	Initiated	Canaccord Genuity	Buy	$30

Show Previous Ratings

May-28-25 04:30PM	CVRx to Present at the William Blair 45th Annual Growth Stock Conference (GlobeNewswire)
May-09-25 03:40AM	CVRx Inc (CVRX) Q1 2025 Earnings Call Highlights: Revenue Growth Amid Sales Force Realignment ... (GuruFocus.com) -38.69%
May-08-25 06:35PM	CVRx (CVRX) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
05:27PM	CVRx: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	CVRx Reports First Quarter 2025 Financial and Operating Results (GlobeNewswire)
11:20AM	Loading…
May-07-25 11:20AM	What To Expect From CVRx Inc (CVRX) Q1 2025 Earnings (GuruFocus.com)
May-06-25 10:00AM	908 Devices Inc. (MASS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
May-01-25 10:01AM	CVRx (CVRX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Apr-24-25 04:30PM	CVRx to Report First Quarter 2025 Financial and Operating Results and Host Conference Call on May 8, 2025 (GlobeNewswire) +6.06%
Apr-09-25 08:45AM	CVRx Inc: Overreaction Creates Buying Opportunity (Seeking Alpha) +17.26%
Apr-07-25 04:05PM	CVRx Reports Preliminary First Quarter 2025 Financial Results (GlobeNewswire) -46.27%
Feb-12-25 02:45PM	CVRx announces new real-world evidence demonstrating significant reductions in healthcare utilization with Barostim (GlobeNewswire)
Feb-11-25 09:55AM	CVRx (CVRX) Forms 'Hammer Chart Pattern': Time for Bottom Fishing? (Zacks)
Feb-07-25 09:55AM	Wall Street Analysts Predict a 25.76% Upside in CVRx (CVRX): Here's What You Should Know (Zacks)
Feb-05-25 02:14AM	CVRx Inc (CVRX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Rising Expenses (GuruFocus.com) -7.20%
05:45PM	Loading…
Feb-04-25 05:45PM	CVRx (CVRX) Reports Q4 Loss, Tops Revenue Estimates (Zacks) +5.11%
04:49PM	CVRx: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	CVRx Reports Fourth Quarter and Full Year 2024 Financial and Operating Results (GlobeNewswire)
Feb-03-25 07:08AM	CVRx Inc (CVRX) Q4 2024 Earnings Report Preview: What To Expect (GuruFocus.com)
Jan-21-25 04:30PM	CVRx to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call on February 4, 2025 (GlobeNewswire) -6.47%
Jan-16-25 10:00AM	CVRx (CVRX) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Jan-13-25 08:00AM	CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2024 Financial Results and Issues Fiscal 2025 Guidance (GlobeNewswire) +6.14%
Dec-23-24 04:30PM	CVRx to Present at the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Nov-26-24 08:31AM	Cvrx (CVRX) Declined Due To Turbulence In The Direct Sales Team (Insider Monkey)
Nov-20-24 04:30PM	CVRx to Present at the Piper Sandler 36th Annual Healthcare Conference (GlobeNewswire) +9.25%
Nov-04-24 08:00AM	CVRx Announces Positive Outpatient Payment for Barostim Procedure in 2025 (GlobeNewswire) +12.31%
Oct-30-24 03:14AM	CVRx Inc (CVRX) Q3 2024 Earnings Call Highlights: Revenue Surge Amid Rising Expenses (GuruFocus.com) +31.01%
Oct-29-24 05:50PM	CVRx (CVRX) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:46PM	CVRx: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	CVRx Reports Third Quarter 2024 Financial and Operating Results (GlobeNewswire)
09:08AM	Loading…
Oct-28-24 09:08AM	Earnings To Watch: CVRx Inc (CVRX) Reports Q3 2024 Result (GuruFocus.com)
Oct-21-24 08:42AM	CVRx (CVRX) Soars 17.2%: Is Further Upside Left in the Stock? (Zacks) +8.11%
06:40AM	CVRx announces new CPT Category I codes for Barostim heart failure therapy (Medical Device Network)
Oct-19-24 02:10PM	CVRx announces new CPT Category I codes for Barostim (TipRanks)
Oct-18-24 02:08PM	CVRx announces new CPT Category I codes for Barostim (GlobeNewswire) +17.16%
Oct-15-24 04:30PM	CVRx to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call on October 29, 2024 (GlobeNewswire)
Sep-12-24 10:13AM	CVRx touts positive two-year data for heart failure neuromodulation device (Medical Device Network) -6.17%
08:00AM	CVRx announces new publication reinforcing the long-term quality of life benefits of Barostim (GlobeNewswire)
Sep-03-24 08:30AM	CVRx Announces Appointment of Two New Board Members (GlobeNewswire) -8.22%
Aug-26-24 09:00PM	Bragar Eagel & Squire, P.C. Is Investigating Arhaus, Cardlytics, and CVRx and Encourages Investors to Contact the Firm (GlobeNewswire) +14.55%
Aug-05-24 07:22PM	Insider Buying Alert: President & CEO Kevin Hykes Acquires 30,000 Shares of CVRx Inc (CVRX) (GuruFocus.com) +6.97%
05:20PM	CVRx, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CVRX (PR Newswire)
Aug-02-24 08:00AM	CVRx Announces Increased Inpatient Payment for Barostim Procedure (GlobeNewswire)
Jul-31-24 04:27PM	CVRx to Present at the Canaccord Genuity 44th Annual Growth Conference (GlobeNewswire) +7.89%
Jul-29-24 05:40PM	CVRx (CVRX) Reports Q2 Loss, Lags Revenue Estimates (Zacks) -14.51%
04:38PM	CVRx: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	CVRx Reports Second Quarter 2024 Financial and Operating Results (GlobeNewswire)
Jul-15-24 04:30PM	CVRx to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call on July 29th, 2024 (GlobeNewswire)
Jul-12-24 11:54AM	Strength Seen in CVRx (CVRX): Can Its 19.0% Jump Turn into More Strength? (Zacks) +14.22%
Jun-25-24 06:50AM	CVRx Announces Appointment of Robert Allen John as Chief Revenue Officer (GlobeNewswire)
Jun-06-24 05:48AM	CVRx (CVRX) Stock Jumps 33.9%: Will It Continue to Soar? (Zacks) +8.40%
May-22-24 08:30AM	CVRx to Present at the William Blair 44th Annual Growth Stock Conference (GlobeNewswire)
May-16-24 07:30AM	CVRx Announces Key Senior Leadership Team Hires (GlobeNewswire)
May-01-24 10:45AM	CVRx, Inc. (NASDAQ:CVRX) Q1 2024 Earnings Call Transcript (Insider Monkey) -34.75%
08:39AM	Why Is CVRx (CVRX) Stock Down 32% Today? (InvestorPlace)
07:42AM	Q1 2024 CVRx Inc Earnings Call (Thomson Reuters StreetEvents)
07:31AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday (InvestorPlace)
Apr-30-24 08:56PM	CVRX Stock Earnings: CVRx Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace)
05:44PM	CVRx Inc (CVRX) Reports Q1 2024 Results: Revenue Growth Amid Challenges (GuruFocus.com)
04:34PM	CVRx: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	CVRx Reports First Quarter 2024 Financial and Operating Results (GlobeNewswire)
Apr-19-24 11:14AM	CVRx's (CVRX) Latest Data Favors Barostim's Long-Term Benefits (Zacks)
Apr-16-24 04:30PM	CVRx to Report First Quarter 2024 Financial and Operating Results and Host Conference Call on April 30th, 2024 (GlobeNewswire)
Apr-15-24 07:30AM	CVRx announces availability of additional data supporting long-term benefits of Barostim (GlobeNewswire)
Jan-31-24 08:00AM	CVRx Announces Appointment of Kevin Hykes as President and Chief Executive Officer (GlobeNewswire)
Jan-27-24 11:10AM	CVRx, Inc. (NASDAQ:CVRX) Q4 2023 Earnings Call Transcript (Insider Monkey)
Jan-26-24 07:14AM	Q4 2023 CVRx Inc Earnings Call (Thomson Reuters StreetEvents) -6.75%
Jan-25-24 05:45PM	CVRx (CVRX) Reports Q4 Loss, Tops Revenue Estimates (Zacks) +5.72%
04:50PM	CVRx: Q4 Earnings Snapshot (Associated Press Finance)
04:39PM	CVRx Inc (CVRX) Reports Substantial Revenue Growth in 2023 (GuruFocus.com)
04:05PM	CVRx Reports Fourth Quarter and Full Year 2023 Financial and Operating Results (GlobeNewswire)
Jan-22-24 12:00PM	CVRx (CVRX) Upgraded to Strong Buy: What Does It Mean for the Stock? (Zacks)
Jan-11-24 04:30PM	CVRx to Report Fourth Quarter 2023 Financial and Operating Results and Host Conference Call on January 25th, 2024 (GlobeNewswire)
08:50AM	What Makes CVRx (CVRX) a Good Fit for 'Trend Investing' (Zacks)
Jan-08-24 08:30AM	CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2023 Financial Results and Announces Nadim Yared Retirement Plans (GlobeNewswire) -5.34%
Dec-27-23 04:30PM	CVRx to Present at the 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire) +7.35%
07:18AM	CVRx (CVRX) Moves 24.2% Higher: Will This Strength Last? (Zacks)
Dec-26-23 08:05AM	CVRx receives FDA approval for expanded labeling of Barostim (GlobeNewswire) +24.21%
Dec-18-23 12:00PM	CVRx (CVRX) Is Up 10.17% in One Week: What You Should Know (Zacks)
Dec-08-23 08:50AM	CVRx (CVRX) is on the Move, Here's Why the Trend Could be Sustainable (Zacks)
Dec-04-23 07:14AM	CVRx (CVRX) Moves 7.1% Higher: Will This Strength Last? (Zacks) +8.49%
Nov-16-23 05:50AM	Looking for Stocks to Buy? Here Are the Companies Johnson & Johnson Is Betting the Most On (Motley Fool)
Nov-15-23 04:21PM	CVRx to Present at the 35th Annual Piper Sandler Healthcare Conference (GlobeNewswire)
Nov-06-23 08:50AM	CVRx (CVRX) is on the Move, Here's Why the Trend Could be Sustainable (Zacks)
Nov-03-23 08:00AM	CMS Increases Outpatient Payment for Barostim Procedure (GlobeNewswire) +29.30%
Oct-31-23 12:00PM	What Makes CVRx (CVRX) a New Strong Buy Stock (Zacks)
Oct-27-23 09:03AM	Q3 2023 CVRx Inc Earnings Call (Thomson Reuters StreetEvents)
08:37AM	CVRx, Inc. (NASDAQ:CVRX) Q3 2023 Earnings Call Transcript (Insider Monkey)
Oct-26-23 06:26PM	CVRx Inc (CVRX) Reports Q3 2023 Financial Results (GuruFocus.com)
06:05PM	CVRx (CVRX) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
05:05PM	CVRx: Q3 Earnings Snapshot (Associated Press Finance)
04:15PM	CVRx Reports Third Quarter 2023 Financial and Operating Results (GlobeNewswire)
Oct-12-23 04:30PM	CVRx to Report Third Quarter 2023 Financial and Operating Results and Host Conference Call on October 26th, 2023 (GlobeNewswire) -6.49%
Jul-27-23 08:30AM	CVRx to Present at the Canaccord Genuity 43rd Annual Growth Conference (GlobeNewswire)
Jul-25-23 06:05PM	CVRx (CVRX) Reports Q2 Loss, Tops Revenue Estimates (Zacks) +5.43%
04:57PM	CVRx: Q2 Earnings Snapshot (Associated Press Finance)
04:15PM	CVRx Reports Second Quarter 2023 Financial and Operating Results (GlobeNewswire)
Jul-11-23 04:30PM	CVRx to Report Second Quarter 2023 Financial and Operating Results and Host Conference Call on July 25th, 2023 (GlobeNewswire) +12.21%
Jul-10-23 10:29AM	Painful week for private equity firms invested in CVRx, Inc. (NASDAQ:CVRX) after 11% drop, institutions also suffered losses (Simply Wall St.)
Jul-03-23 07:12AM	CVRx (CVRX) Surges 7.2%: Is This an Indication of Further Gains? (Zacks)

CVRx, Inc. engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It operates through the following geographical segments: United States, Germany, and Other Countries. The company was founded by Robert S. Kieval and Tyler P. Lipschultz in August 2001 and is headquartered in Minneapolis, MN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Nielsen Kirk G.	Director	May 15 '25	Buy	5.45	10,966	59,795	1,910,134	May 19 06:46 PM
Nielsen Kirk G.	Director	May 13 '25	Buy	5.29	101,413	536,313	1,837,968	May 14 05:27 PM
Nielsen Kirk G.	Director	May 14 '25	Buy	5.23	61,200	320,364	1,899,168	May 14 05:27 PM
Nielsen Kirk G.	Director	May 12 '25	Buy	4.79	25,200	120,670	1,736,555	May 14 05:27 PM
Jain Mudit K.	Director	May 12 '25	Buy	4.66	1,500	6,986	4,900	May 13 07:12 PM
Jain Mudit K.	Director	May 13 '25	Buy	5.26	150	789	5,050	May 13 07:12 PM
Hykes Kevin	PRES & CEO	May 12 '25	Buy	4.84	5,000	24,200	133,000	May 12 07:07 PM
Behbahani Ali	Officer	Nov 29 '24	Proposed Sale	15.30	21,837	334,106		Nov 29 02:19 PM
VERRASTRO PAUL	CHIEF MKTG & STRAT OFFICER	Nov 19 '24	Option Exercise	5.14	2,500	12,852	3,305	Nov 21 07:05 PM
VERRASTRO PAUL	CHIEF MKTG & STRAT OFFICER	Nov 19 '24	Sale	13.58	1,430	19,417	1,875	Nov 21 07:05 PM
PAUL VERRASTRO	Officer	Nov 19 '24	Proposed Sale	13.58	1,430	19,417		Nov 19 04:27 PM
Behbahani Ali	Officer	Nov 18 '24	Proposed Sale	14.07	9	127		Nov 18 04:34 PM
New Enterprise Associates VIII	Affiliate	Nov 05 '24	Proposed Sale	15.05	171,071	2,574,619		Nov 05 05:36 PM
NEA Enterprise Associates 8A,	Affiliate	Nov 05 '24	Proposed Sale	15.05	173,388	2,609,489		Nov 05 05:35 PM
SLATTERY JOSEPH P	Director	Aug 15 '24	Buy	8.10	3,000	24,300	30,645	Aug 15 07:18 PM
SLATTERY JOSEPH P	Director	Aug 08 '24	Buy	8.24	3,000	24,716	27,645	Aug 08 04:18 PM
SLATTERY JOSEPH P	Director	Aug 06 '24	Buy	9.09	2,500	22,725	24,645	Aug 06 04:43 PM
Hykes Kevin	PRES & CEO	Aug 05 '24	Buy	8.36	30,000	250,767	30,000	Aug 05 04:56 PM
Palmer Craig E.	Officer	Jul 26 '24	Proposed Sale	9.60	18,243	175,064		Jul 26 05:48 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CVRX

CVRx Inc

Upgrade your FINVIZ experience